Amy Sheen

1.2k total citations
30 papers, 627 citations indexed

About

Amy Sheen is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amy Sheen has authored 30 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amy Sheen's work include Neuroendocrine Tumor Research Advances (6 papers), Genetic factors in colorectal cancer (6 papers) and Occupational and environmental lung diseases (6 papers). Amy Sheen is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Genetic factors in colorectal cancer (6 papers) and Occupational and environmental lung diseases (6 papers). Amy Sheen collaborates with scholars based in Australia, United States and Egypt. Amy Sheen's co-authors include Anthony J. Gill, Loretta Sioson, Adele Clarkson, Angela Chou, Juliana Andrici, Mahsa Ahadi, Talia L. Fuchs, Christopher W. Toon, John Turchini and Mahtab Farzin and has published in prestigious journals such as The American Journal of Surgical Pathology, European Journal of Pharmacology and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

Amy Sheen

30 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Sheen Australia 15 250 247 118 116 116 30 627
Joanna Gale United Kingdom 8 323 1.3× 143 0.6× 79 0.7× 143 1.2× 52 0.4× 22 641
Bart Rikhof Netherlands 11 227 0.9× 114 0.5× 63 0.5× 38 0.3× 159 1.4× 14 490
Elisabetta Froio Italy 14 88 0.4× 189 0.8× 149 1.3× 83 0.7× 56 0.5× 38 453
Trisha M. Shattuck United States 8 133 0.5× 377 1.5× 222 1.9× 173 1.5× 163 1.4× 13 902
Barbara Gazić Slovenia 13 80 0.3× 140 0.6× 60 0.5× 130 1.1× 85 0.7× 45 506
Shafei Wu China 16 338 1.4× 440 1.8× 54 0.5× 162 1.4× 172 1.5× 59 720
Jacek Sygut Poland 13 175 0.7× 142 0.6× 31 0.3× 200 1.7× 68 0.6× 45 496
Rieke Fischer Germany 9 270 1.1× 503 2.0× 41 0.3× 62 0.5× 60 0.5× 33 675
Hiroyuki Yamaoka Japan 13 103 0.4× 146 0.6× 79 0.7× 81 0.7× 69 0.6× 37 471
Zeynep Gözde Özkan Türkiye 14 121 0.5× 243 1.0× 131 1.1× 111 1.0× 47 0.4× 40 518

Countries citing papers authored by Amy Sheen

Since Specialization
Citations

This map shows the geographic impact of Amy Sheen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Sheen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Sheen more than expected).

Fields of papers citing papers by Amy Sheen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Sheen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Sheen. The network helps show where Amy Sheen may publish in the future.

Co-authorship network of co-authors of Amy Sheen

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Sheen. A scholar is included among the top collaborators of Amy Sheen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Sheen. Amy Sheen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McKay, Matthew J., Mark P. Molloy, Loretta Sioson, et al.. (2024). Novel combinatorial autophagy inhibition therapy for triple negative breast cancers. European Journal of Pharmacology. 973. 176568–176568. 2 indexed citations
2.
3.
McKay, Matthew J., Mark P. Molloy, Loretta Sioson, et al.. (2023). Inhibition of autophagy initiation: A novel strategy for oral squamous cell carcinomas. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(2). 119627–119627. 6 indexed citations
4.
Turchini, John, Loretta Sioson, Adele Clarkson, et al.. (2023). The Presence of Typical “BRAFV600E-Like” Atypia in Papillary Thyroid Carcinoma is Highly Specific for the Presence of the BRAFV600E Mutation. Endocrine Pathology. 34(1). 112–118. 12 indexed citations
5.
Turchini, John, Talia L. Fuchs, Angela Chou, et al.. (2023). A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma—How Much? How Tall? And When Is It Relevant?. Endocrine Pathology. 34(4). 461–470. 4 indexed citations
6.
Fuchs, Talia L., Catherine Luxford, Adele Clarkson, et al.. (2022). A Clinicopathologic and Molecular Analysis of Fumarate Hydratase–deficient Pheochromocytoma and Paraganglioma. The American Journal of Surgical Pathology. 47(1). 25–36. 11 indexed citations
7.
Fuchs, Talia L., Angela Chou, Loretta Sioson, et al.. (2022). What are the problems with the current staging of discontinuous tumour nodules (DTNs) in colorectal carcinoma? Is there a better way?. Pathology. 54(7). 848–854. 2 indexed citations
8.
Turchini, John, Loretta Sioson, Adele Clarkson, Amy Sheen, & Anthony J. Gill. (2021). PD-L1 Is Preferentially Expressed in PIT-1 Positive Pituitary Neuroendocrine Tumours. Endocrine Pathology. 32(3). 408–414. 17 indexed citations
9.
10.
Fuchs, Talia L., A. Scott Pearson, Connie I. Diakos, et al.. (2020). Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases. Pathology. 52(5). 515–521. 3 indexed citations
11.
Turchini, John, Loretta Sioson, Adele Clarkson, Amy Sheen, & Anthony J. Gill. (2020). Utility of GATA-3 Expression in the Analysis of Pituitary Neuroendocrine Tumour (PitNET) Transcription Factors. Endocrine Pathology. 31(2). 150–155. 21 indexed citations
12.
Fuchs, Talia L., Angela Chou, Loretta Sioson, Amy Sheen, & Anthony J. Gill. (2020). Stromal tumour‐infiltrating lymphocytes (TILs) assessed using the ITWG system do not predict overall survival in a cohort of 337 cases of mesothelioma. Histopathology. 76(7). 1095–1101. 4 indexed citations
13.
Chou, Angela, Mahsa Ahadi, Talia L. Fuchs, et al.. (2019). NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas—a study of 4569 cases. Modern Pathology. 33(5). 924–932. 46 indexed citations
14.
Chou, Angela, Malinda Itchins, Philip R. de Reuver, et al.. (2018). ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors. Human Pathology. 82. 249–257. 38 indexed citations
15.
Wang, Jennifer, Juliana Andrici, Loretta Sioson, et al.. (2016). Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency. Human Pathology. 55. 83–90. 19 indexed citations
16.
Ahadi, Mahsa, Juliana Andrici, Loretta Sioson, et al.. (2016). Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma. Human Pathology. 57. 91–97. 16 indexed citations
17.
Chua, Terence C., et al.. (2016). Resection margin influences survival after pancreatoduodenectomy for distal cholangiocarcinoma. The American Journal of Surgery. 213(6). 1072–1076. 17 indexed citations
18.
Andrici, Juliana, Mahtab Farzin, Adele Clarkson, et al.. (2016). Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms. Pathology. 48(4). 319–324. 13 indexed citations
19.
Andrici, Juliana, Amy Sheen, Loretta Sioson, et al.. (2015). Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology. Modern Pathology. 28(10). 1360–1368. 74 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanna Gale Breakdown of academic impact, for papers by Bart Rikhof Breakdown of academic impact, for papers by Elisabetta Froio Breakdown of academic impact, for papers by Trisha M. Shattuck Breakdown of academic impact, for papers by Barbara Gazić Breakdown of academic impact, for papers by Shafei Wu Breakdown of academic impact, for papers by Jacek Sygut Breakdown of academic impact, for papers by Rieke Fischer Breakdown of academic impact, for papers by Hiroyuki Yamaoka Breakdown of academic impact, for papers by Zeynep Gözde Özkan
Rankless by CCL
2026